CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Clase Neera Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +10,587 | 10,587 | ||
| 2026-11-03 | Clase Neera Chief Commercial Officer | Grant or award · Restricted Stock Units | +6,678 | 6,678 | ||
| 2026-09-15 | LINK WILLIAM J PHD Director | Option exercise 10b5-1 | +201 | 106,987 | ||
| 2026-09-15 | LINK WILLIAM J PHD Director | Sale 10b5-1 | −11,675 | $78.33 | $915K | 95,312 |
| 2026-09-15 | LINK WILLIAM J PHD Director | Sale 10b5-1 | −759 | $79.00 | $60K | 94,553 |
| 2026-09-15 | LINK WILLIAM J PHD Director | Sale 10b5-1 | −66 | $80.01 | $5K | 94,487 |
| 2026-09-15 | LINK WILLIAM J PHD Director | Option exercise · Restricted Stock Units 10b5-1 | −201 | 605 | ||
| 2026-09-15 | YARNO WENDY L Director | Option exercise | +302 | 16,956 | ||
| 2026-09-15 | YARNO WENDY L Director | Option exercise · Restricted Stock Units | −302 | 907 | ||
| 2026-09-15 | PYOTT DAVID E I Director | Option exercise | +201 | 9,575 | ||
| 2026-09-15 | PYOTT DAVID E I Director | Option exercise · Restricted Stock Units | −201 | 605 | ||
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −5,387 | $85.00 | $458K | 7,933 |
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −5,386 | $90.00 | $485K | 2,547 |
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −1,590 | $85.00 | $135K | 3,180 |
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −1,590 | $90.00 | $143K | 1,590 |
| 2026-09-04 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −7,100 | $90.27 | $641K | 830,891 |
| 2026-09-04 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −2,900 | $91.27 | $265K | 827,991 |
| 2026-09-04 | Neervannan Seshadri Chief Operating Officer | Sale 10b5-1 | −4,564 | $85.00 | $388K | 78,532 |
| 2026-09-02 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −5,387 | $80.00 | $431K | 13,320 |
| 2026-09-02 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −1,590 | $80.00 | $127K | 4,770 |
Page 1 of 13 · 257 trades